Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000019617-13-000021
Filing Date
2013-01-08
Accepted
2013-01-08 14:47:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 CUMBERLAND PHARMACEUTICALS INC. SC 13G/A Cumberlandpharinc_v3.htm SC 13G/A 33698
  Complete submission text file 0000019617-13-000021.txt   35498
Mailing Address 270 PARK AVENUE NEW YORK NY 10017
Business Address 270 PARK AVE 38TH FL NEW YORK NY 10017 2122706000
JPMORGAN CHASE & CO (Filed by) CIK: 0000019617 (see all company filings)

EIN.: 132624428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6021 National Commercial Banks

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Subject) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: SC 13G/A | Act: 34 | File No.: 005-85205 | Film No.: 13517787
SIC: 2834 Pharmaceutical Preparations